Long term responders to palliative chemotherapy for advanced biliary tract cancer.
McNamara, Mairéad G
AffiliationDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
MetadataShow full item record
AbstractPatients with advanced biliary tract cancer (BTC) are often treated with palliative chemotherapy (PC). Standard PC since 2010 is a cisplatin/gemcitabine doublet, with median overall survival (OS) of 11.7 months from the ABC-02 trial. Prior to this, our institutional standard was gemcitabine and fluoropyrimidine. The ABC-02 study used 8 cycles of PC as standard with treatment stopped even in the absence of disease progression, but some patients may benefit from continuing PC longer than 8 cycles.
CitationLong term responders to palliative chemotherapy for advanced biliary tract cancer. 2017, 8 (2):352-360 J Gastrointest Oncol
JournalJournal of Gastrointestinal Oncology